A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy

Patents for A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964)
11/2004
11/25/2004	WO2004085468A3 Human p53 splice variant displaying differential transcriptional activity
11/25/2004	WO2004078123A3 Early prostate cancer antigens (epca), polynucleotide sequences encoding them, and their use
11/25/2004	WO2004074428A3 Treatment of metabolic disorders
11/25/2004	WO2004073646A3 Treatment of pain through expression of opioid receptors
11/25/2004	WO2004067736A3 Custom-made meganuclease and use thereof
11/25/2004	WO2004037294A3 New settings for recombinant adenoviral-based vaccines
11/25/2004	WO2003092594A8 Adeno-associated viral vectors and methods for their production from hybrid adenovirus and for their use
11/25/2004	WO2003086280A3 Immunostimulatory g,u-containing oligoribonucleotides
11/25/2004	WO2003070906A3 Cellular genes regulated by hiv-1 infection and methods of use thereof
11/25/2004	US20040237127 Composition and methods for the therapeutic use of an atonal-associated sequence for deafness, osteoarthritis and abnormal cell proliferation
11/25/2004	US20040236093 Using chimeric dendritic cells comprising viral epitopes to generate vaccines to prevent and treat viral diseases
11/25/2004	US20040236072 Immunogenic polynucleotides, polypeptides, and antibodies used for detecting, immunizing against, and reducing beta-hemolytic streptococcal infection
11/25/2004	US20040235775 Inhibition of hepatitis B virus (HBV) replication by RNA interference
11/25/2004	US20040235769 Anti-tumor effects of prostage Carcinoma Tumor Antigen-1
11/25/2004	US20040235767 Synergistic mixture comprises cell adhesion molecule or a mammalian expression vector containing DNA; gene therapy; antitumor agents
11/25/2004	US20040235764 Methods of inhibiting expression of a target gene in mammalian cells
11/25/2004	US20040235763 Expression vector involved in proliferation or replication, or immune protection of HSV; or transcriptional and/or translational products of target sequence
11/25/2004	US20040235741 Human papilloma virus treatment
11/25/2004	US20040235736 Combined tumor suppressor gene therapy and chemotherapy in the treatment of neoplasms
11/25/2004	US20040235721 Relates to polynucleotides coding for PPVO viral genome, to fragments of polynucleotides coding for PPVO genome and to polynucleotides coding for individual open reading frames of PPVO viral genome; for treatment of viral, non-viral infections, proliferative, inflammatory, autoimmune diseases
11/25/2004	US20040235720 May also be used in combination with an interferon for treatment and/or prevention of diseases such as traumatic nerve injury, stroke, demyelinating diseases of the CNS or PNS, neuropathies and neurodegenerative diseases
11/25/2004	US20040235175 Method for transfection of rna using electrical pulses
11/25/2004	US20040235170 Prosthetic grafts
11/25/2004	US20040235169 Lentiviral expression vector for use as gene transfer tool in genetic engineerning; heterologous gene expression and tissue engineering; bioreactors
11/25/2004	US20040235134 Newcastle disease virus infectious clones, vaccines and new diagnostic assays
11/25/2004	US20040235133 Large scale production of packaged alphavirus replicons
11/25/2004	US20040235129 KDEL receptor inhibitors
11/25/2004	US20040235116 Novel proteins in enteroaggregative Escherichia coli (EAEC) useful for diagnosis and therapy of EAEC infections
11/25/2004	US20040235106 18891, a novel human lipase
11/25/2004	US20040235097 Whitefly ecdysone receptor nucleic acids, polypeptides, and uses thereof
11/25/2004	US20040235095 Proaerolysin containing protease activation sequences and methods of use for treatment of prostate cancer
11/25/2004	US20040235083 Screening method
11/25/2004	US20040235070 Immune reactivity to expressed activated oncogenes for diagnosis and treatment of malignancy
11/25/2004	US20040235066 Using immunoglobulin specific to cancer testis-antigens for use in diagnosis and treatment of cell proliferative diseaes; immunotherapy
11/25/2004	US20040235041 Nucleic acids containing single nucleotide polymorphisms and methods of use thereof
11/25/2004	US20040235038 Using single-stranded conformational polymorphisms to identify mutation which lead to cardiovascular disorders; identifying modulator for treatment of cardiac disorders
11/25/2004	US20040235018 Nucleotide sequences coding zinc finger protein for use in identifying modulators of cell proliferation disorders; antitumor agents
11/25/2004	US20040235011 Production of multimeric proteins
11/25/2004	US20040234999 Biopolymer mixtures for use in the inhibition of gene expression; RNA interference and gene therapy
11/25/2004	US20040234997 De novo DNA cytosine methyltransferase genes, polypeptides and uses thereof
11/25/2004	US20040234993 Comprises nucleotide sequences coding membrane protein for use in identifying modulators for prevention and treatment of asthma, chronic obstructive pulmonary disease (COPD) and arthritis
11/25/2004	US20040234965 Novel pathways involved in epigenetic memory
11/25/2004	US20040234959 Truncated bard1 protein, and its diagnostic and therapeutic uses
11/25/2004	US20040234953 Viral nucleotide sequences coding envelope proteins for use in preparing antibodies for prevention and treatment of autoimmune disorders
11/25/2004	US20040234950 Method for virus propagation
11/25/2004	US20040234948 Simian viral gene transfer construct comprising and capable of displaying vesicular stomatitis virus glycoprotein sequences for use as tool in generating transgenic embryonic stem cell; tissue engineering
11/25/2004	US20040234586 Compositions and methods for enhancing nucleic acid transfer into cells
11/25/2004	US20040234552 Avian-paramyxovirus nucleotide sequence; attenuation live vaccine
11/25/2004	US20040234536 Polypeptide containing antigen segment; mixture with antibodies; immunostimulants
11/25/2004	US20040234529 Helicobacter pylori adhesin binding group antigen
11/25/2004	US20040234527 Peptides for use as translocation factors
11/25/2004	US20040234526 Use of a compound antagonist of esm-1 protein for producing a medicine for treating cancer
11/25/2004	US20040234523 Antiischemic agents; synergistic mixture of interleukin inhibitor and tumor necrosis factor antagonist
11/25/2004	US20040234518 Composition, methods and reagents for the synthesis of a soluble form of human PHEX
11/25/2004	US20040234509 Replacing liver cells with bone marrow-derived cells for treating disease and expressing therapeutic genes
11/25/2004	US20040234505 Polynucleotide constructs and uses thereof
11/25/2004	US20040234504 Lentiviral vector; nucleic acids; in situ genetic engineering
11/25/2004	US20040234502 Method for treatment of vascular regeneration
11/25/2004	US20040234481 Gene transfers of angiogenic factor for skin disease
11/25/2004	US20040234472 Micellar drug delivery systems for hydrophobic drugs
11/25/2004	CA2527756A1 Immunostimulating agents
11/25/2004	CA2525929A1 Methods of modulating metastasis and skeletal related events resulting from metastases
11/25/2004	CA2525385A1 Grp94-based compositions and methods of use thereof
11/25/2004	CA2524499A1 Broadening adenovirus tropism
11/25/2004	CA2522614A1 Vaccine accelerator factor (vaf) for improvement of vaccinations in poultry
11/24/2004	EP1479768A1 Novel screening method
11/24/2004	EP1479398A1 AGENT CONTROLLING THE APOPTOSIS INDUCTION BY p73
11/24/2004	EP1478784A2 Method and nucleic acids for the analysis of colorectal cell proliferative disorders
11/24/2004	EP1478778A2 Method and nucleic acids for the analysis of a colon cell proliferactive disorder
11/24/2004	EP1478759A1 Retroviral vectors pseudotyped with influenza virus hemagglutinin for gene delivery
11/24/2004	EP1478758A1 Polymorphisms in elastin, fibrillin, and related genes as predisposing to restenosis and to atherosclerosis
11/24/2004	EP1478750A2 Gene expression by positive feedback activation of a cell type-specific promoter
11/24/2004	EP1478730A2 RNA INTERFERENCE MEDIATED INHIBITION OF TNF AND TNF RECEPTOR SUPERFAMILY GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA)
11/24/2004	EP1478664A1 Tissue specific expression
11/24/2004	EP1478656A2 Oligonucleotide compositions with enhanced efficiency
11/24/2004	EP1478390A2 Novel complexes for inducing an immune response
11/24/2004	EP1478371A2 Methods and products for enhancing immune responses using imidazoquinoline compounds
11/24/2004	EP1478354A2 Use of tgf-beta antagonists to treat or to prevent chronic transplant rejection
11/24/2004	EP1478236A2 Targeted retrograde gene delivery to motor neurons
11/24/2004	EP1416973A4 Modulation of mhc class i antigen presentation
11/24/2004	EP1214340B1 Mutated anthrax toxin protective antigen proteins that specifically target cells containing high amounts of cell-surface metalloproteinases or plasminogen activator receptors
11/24/2004	EP1183231B1 Cytofectin dimers and methods of use thereof
11/24/2004	EP1171587B1 Peptide from antigen muc-1 for triggering an immune response to tumor cells
11/24/2004	EP1140023B1 Integrative protein-dna cochleate formulations and methods for transforming cells
11/24/2004	EP1115452B1 System for treating ischemia
11/24/2004	EP1027014B1 Implantable system with drug-eluting cells for on-demand local drug delivery
11/24/2004	EP1007677B1 Protease-related protein
11/24/2004	EP0951481B1 Use of substances with immunomodulating activity for the treatment of amyotrophic lateral sclerosis
11/24/2004	EP0929318B1 Melanoma cell lines expressing shared immunodominant melanoma antigens and methods of using same
11/24/2004	EP0889731B1 Injectable therapy for control of muscle spasms and pain related to muscle spasms
11/24/2004	EP0830140B1 A pluripotent vaccine against enveloped viruses
11/24/2004	CN1549826A Compositions and methods of treating diabetes
11/24/2004	CN1549824A Peptidic compounds selectively binding to p-selectin
11/24/2004	CN1549730A Compositions and methods of using capsid protein from flaviviruses and pestiviruses
11/24/2004	CN1549729A 化合物 Compound
11/24/2004	CN1548542A Recombinant DNA plasmid, its construction process, mutivalent vaccine containing the plasmid and its application
11/24/2004	CN1548452A One kind of membrane protein of SARS coronavirus and its encoding gene and application
11/24/2004	CN1177057C Recombinant of viral vector and human tumor suppressor gene, and use thereof
11/24/2004	CN1177046C Enhanced virus-mediated DNA transfer
11/24/2004	CN1176937C Double-stranded RNA and use thereof

1 ... 416 417 418 419 420 421 422 423 424 425 426 427 428 429 430 431 432 433 434 435 436 ... 870